KATHRYN CURRIER: Open Payments
NPI 1073243986 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$450 in 17 payments from 8 companies in 2025. Trend: 2023 $758 · 2024 $678 · 2025 $450
Food & beverage: $450
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $163 |
| ABBVIE INC. | 3 | $76 |
| SANOFI-AVENTIS U.S. LLC | 3 | $74 |
| Lilly USA, LLC | 2 | $38 |
| Novo Nordisk Inc | 2 | $30 |
| Exact Sciences Corporation | 2 | $29 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
Products named: BREZTRI, TZIELD, QULIPTA, FARXIGA, UBRELVY, VRAYLAR, Kerendia, JARDIANCE.
Industry payments across AL — which companies pay providers there.
